Robert Wasserman
Stock Analyst at Benchmark Co.
(4.15)
# 1,537
Out of 4,468 analysts
230
Total ratings
45.1%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRLB Proto Labs | Maintained: Buy | $70 → $91 | $76.40 | +19.11% | 15 | Jul 2, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $70.83 | - | 18 | Jun 30, 2026 | |
| XOMA XOMA Royalty | Downgraded: Hold | n/a | $43.00 | - | 4 | May 22, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $95.14 | -0.15% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $90 | $79.45 | +13.28% | 22 | Feb 19, 2026 | |
| TLV: KMDA Kamada Ltd. | Maintained: Buy | ILA 4,470 | $2,250.00 | +98.67% | 4 | Jan 8, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $220 | $319.55 | -31.15% | 19 | Dec 10, 2025 | |
| CDXS Codexis | Maintained: Hold | n/a | $2.47 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Maintained: Buy | $6 → $4 | $2.42 | +65.29% | 11 | Nov 6, 2025 | |
| INTS Intensity Therapeutics | Maintained: Buy | $38 | $4.24 | +784.43% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $142.40 | - | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.11 | - | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $3.40 | +47.06% | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $28.11 | +6.72% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $8.28 | +44.93% | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.57 | +91.08% | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $5.36 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $523.44 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $197.93 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.76 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $80 | $2.16 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.04 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.14 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.52 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $1.63 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $3.15 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.37 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $1.07 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.49 | n/a | 1 | Mar 12, 2013 |
Proto Labs
Jul 2, 2026
Maintained: Buy
Price Target: $70 → $91
Current: $76.40
Upside: +19.11%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $70.83
Upside: -
XOMA Royalty
May 22, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.00
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $95.14
Upside: -0.15%
Halozyme Therapeutics
Feb 19, 2026
Maintained: Buy
Price Target: $90
Current: $79.45
Upside: +13.28%
Kamada Ltd.
Jan 8, 2026
Maintained: Buy
Price Target: ILA 4,470
Current: $2,250.00
Upside: +98.67%
Ligand Pharmaceuticals
Dec 10, 2025
Maintained: Buy
Price Target: $220
Current: $319.55
Upside: -31.15%
Codexis
Nov 14, 2025
Maintained: Hold
Price Target: n/a
Current: $2.47
Upside: -
OmniAb
Nov 6, 2025
Maintained: Buy
Price Target: $6 → $4
Current: $2.42
Upside: +65.29%
Intensity Therapeutics
Oct 31, 2025
Maintained: Buy
Price Target: $38
Current: $4.24
Upside: +784.43%
Oct 29, 2025
Maintained: Hold
Price Target: n/a
Current: $142.40
Upside: -
Aug 13, 2025
Maintained: Hold
Price Target: n/a
Current: $8.11
Upside: -
Aug 12, 2025
Maintained: Buy
Price Target: $5
Current: $3.40
Upside: +47.06%
Aug 11, 2025
Maintained: Buy
Price Target: $30
Current: $28.11
Upside: +6.72%
Aug 8, 2025
Maintained: Buy
Price Target: $12
Current: $8.28
Upside: +44.93%
Jul 31, 2025
Maintained: Buy
Price Target: $3
Current: $1.57
Upside: +91.08%
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $5.36
Upside: n/a
Oct 26, 2023
Maintained: Hold
Price Target: n/a
Current: $523.44
Upside: n/a
Oct 25, 2023
Maintained: Hold
Price Target: n/a
Current: $197.93
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: n/a
Current: $5.76
Upside: n/a
Apr 4, 2023
Maintained: Buy
Price Target: $9 → $80
Current: $2.16
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $3.04
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.14
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.52
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $1.63
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $3.15
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $2.37
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $1.07
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $3.49
Upside: n/a